Preserving Intellectual Property with a Structured Document Management System
May17

Preserving Intellectual Property with a Structured Document Management System

The value of an early stage life science company is tied to its documentation. Transitioning from an informal environment where documents exist on local desktops, email exchanges and in extreme cases of old world technology, filing cabinets, to a structured, digital document system is a key step in securing a company’s intellectual property. Risk of losing files or the most recent versions of files, due to simple human error, increases in orders of magnitude as your stack of documents and team grows over time.

Read More

Drug Development Costs Rise to $1.3 Billion

The cost of bringing a new drug to market is often cited as $1.3B according to a Tufts University study from several years ago. In this study, the $1.3B estimate is an increase of 60% from the previous estimate of $800M. Much of the cost associated with drug development is attributed to resources invested in drugs that never make it to market. Only one out of 10 drugs that are used as part of a clinical trial will become a marketed...

Read More

Why are Drug Samples Disappearing?

The amount of drug samples provided to physician offices has dramatically decreased since 2007. From the period of time beginning 2007 to 2011, drug makers spent 25% less on drug samples which equates to $2.1 billionĀ¹. What’s behind this precipitous drop? Naturally, the cost-cutting measures undertaken by the pharmaceutical industry has impacted the number of samples provided by drug representatives. Nonetheless, the savings...

Read More

MIT’s DRACO is a Novel Approach to Fighting Viral Pathogens

An innovative approach to fight viral pathogens has been discovered by researchers at the Massachusetts Institute of Technology (MIT). The new drug DRACO, an acronym for double-stranded RNA activated caspase oligomerizers, has the potential to fight many known viruses, including the common cold, flu, stomach viruses, polio, and many more. While the drug is still several years away from clinical trials, DRACO has seen early success in...

Read More
Globalization of Drug Supply Carries Risks
Jun15

Globalization of Drug Supply Carries Risks

The amount of pharmaceuticals traded increases every year. In the US, imports comprise 40% of the drugs consumed and 80% of the ingredients needed to manufacture drugs. While such trade bolsters the economies of many countries and lowers the price of medicines by creating competition, real risks have affected the supply chain.

Read More